To clarify the clinical significance of elevation of serum aminotransferase levels in anorexia nervosa, we analyzed the relationships of serum aminotransferase levels to other serum biochemistry and physical conditions before and during refeeding therapy in 101 patients with anorexia nervosa. Before refeeding therapy, body mass index (BMI) was distributed from 9.9 to 16.4 kg/m2 (13.2 ± 1.3, mean ± SD), and 29 patients (28.7 % ) showed abnormally high aminotransferase levels. Among17 patients with a BMIof less than 12 kg/m2, the aminotransferase level was abnormally high in 13 patients (76 % ). Incidence and severity of serum aminotransferase elevation were greater in the patients with lower BMI. The groups with high serum aminotransferase levels had a lower body temperature, lower pulse rate, and higher incidence of other biochemical abnormalities than the group with normal serum aminotransferase levels. These findings indicate that aminotransferase elevation develops at a high incidence in anorectic patients with a critically life-threatening condition, and it is a sign of multiorgan failure requiring urgent calorie repletion. This type of aminotransferase elevation is to be distinguished from refeeding-induced aminotransferase elevation.
Introduction
Anorexia nervosa is a treatable but an intractable psychosomatic disease in young patients, and its mortality is still unacceptably substantial.
Death in weight losing patients with anorexia nervosa seems to be simply due to the deranged metabolism induced by severe limitation of energy source. Thus, the timely institution of appropriate medical management, beyond psychotherapy, is of extreme importance to save lives in severe cases. However, unfortunately, the life-threatening severe conditions of the disease often tend to be overlooked because of the apparently energetic appearance of the patients, and their steadfast denial that they are severely ill. Therefore, if an objective marker or indicator of the life-threatening critical condition of patients exists in routine biochemical examinations, it would be extremely valuable. Although many kinds of biochemical abnormalities , including endocrinological abnormalities, have already been well documented in anorexia nervosa (1, 2), they are not necessarily good indicators of lifethreatening metabolic derangement, and moreover someexaminations require several days to obtain the results in routine laboratory activity.
In the early 1980's we treated a case ofa severely emaciated patient with anorexia nervosa who died shortly after admission showing markedly elevated aminotransferase levels. By a retrospective analysis of medical records of patients with anorexia nervosa admitted in our hospital during 1980-1984, we found manyother cases showing aminotransferase elevation to a varied extent. Thus, we started a prospective study to clarify the clinical implication of serum aminotransferase elevation in anorexia nervosa. To date, numerous studies have discussed the elevation of serum aminotransferase levels in the patients with anorexia nervosa (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . However, there have been no consistent patterns in the results and the clinical implication has not been clarified (2) . Here, we report the results of our prospective studies on the incidence and extent of aminotransferase elevation, its relationships to the other biochemical and physical findings, and its response to therapy, in a consecutive sampling of 101 hospitalized patients with anorexia nervosa.
Anorexia Nervosa and Elevation of SerumAminotransferase

Materials and Methods
Subjects and treatment
The present study enrolled 101 inpatients with anorexia nervosa at the Department ofEndocrinology and Metabolism at the Toranomon Hospital from 1985 to 1996. Patients taking psychoactive medications were excluded from the study because such drugs can induce hepatic disorders. Patients positive for hepatitis B antigen and/or hepatitis C antibody were also excluded from the study. All subjects were Japanese females, ranging in age from 1 3.5 to 36.9 years (21.0± 5.5 years, mean± SD). Heightrangedfrom 146.2 to 169.5 cm (156.8 ± 4.8, mean ± SD). The diagnosis of anorexia nervosa wasbased on the criteria of the Research Committee for Anorexia Nervosa of the Japanese Ministry of Health and Welfare (14): (1) loss of more than 20% of standard body weight; (2) presence of an eating disorder; (3) disturbance of body image reflected by an inappropriate desire to lose weight; (4) onsetbefore 30 years of age; (5) amenorrhea, and (6) absence of any other physical illness. All subjects also met the criteria of DSM-III-R or IV (Diagnostic and Statistical Manual of Mental Disorders, Third edition, Revised, or Fourth edition) ( 15, 16). The refeeding program consisted of encouragement to eat regularly and in 39 patients, an additional intravenous hyperalimentation was given at approximately 500 kcal/day which was subsequently increased, in a stepwise manner, to 750, 1,000, 1,300, and 1,600 kcal/day. Maximum calories intravenously administered were 1 ,300-1 ,600 kcal/day.
Assessment of physical condition and serum biochemistry Bodyweight and blood pressure, pulse rate were measured every morning during hospitalization. The body mass index (BMI) was calculated from the ratio of weight (kg) to squared height (m2). Examinations for serum biochemistries were performed on the venous blood drawn under stable fasting condition in the early morning of the day following admission and at regular intervals (every 4-7 days) during hospitalization. Serum total protein (TP), albumin (Alb), bilirubin (Bil), aspartate aminotransferase (AST , GOT), alanine aminotransferase (ALT, GPT), lactate dehydrogenase (LDH), alkaline phosphatase (AlP), y-glutamyltransferase (y-GT), leucine aminopeptidase (LAP), choline esterase (ChE), ferritin, amylase, creatine kinase (CK), blood urea nitrogen (BUN), creatinine (Cre), cholesterol (Cholest), and coagulation activities were determined with routine laboratory methods. This study was approved by the committee of the Institute of HumanRights.
Sta tistics
All data ofbiochemical and physical findings of each group are expressed as the median, maximumand minimum,and statistical differences between groups were analyzed by the Mann-Whitney U test or Kruskal-Wallis test. Correlations of variables to BMIwere assessed using univariate linear regression analysis. Common logarithms to the serum ALT,AST, LDH,amylase and ferritin levels were used to obtain the best possible linear models and, in this way, make sure that the residuals were as small as possible. The changes of aminotransferase levels during the refeeding therapy were shown after transformed to their logarithms and statistically analyzed by Friedman's test. Changes of the biochemical data after the refeeding were analyzed by the Wilcoxon signed rank test. A p value less than 0.05 was considered statistically significant.
Results
Aminotransferase levels before effective refeeding therapy Aminotransferase levels at the point of the nadir of body weight before effective refeeding therapy were analyzed. The lowest body weight in an individual patient was observed on admission or on the following day (N = 66), 3-5 hospital day (N = 16), 6-9 hospital day (N = ll), or later (N = 8). The lowest BMIin each individual before the effective refeeding therapy was distributed from 9.9 to 16.4 kg/m2 (13.2 ± 1.3, mean ± SD) in this study.
Whenthe body weight was the lowest before effective refeeding therapy, 29 among 101 anorectic patients showed abnormally high serum ALTand ASTlevels. These 29 patients were divided into two groups by the severity of aminotransferase elevation: i.e. Group 1 (13 patients) of marked elevation of serum aminotransferase levels (ALT: >200 U//; and/or AST: >200 U//) and Group 2 ( 16 patients) of mildly high aminotransferase levels (ALT: >50 U//, and/or AST: >40 U/Z). Serum aminotransferase levels were normal in the other 72 patients (Group 3).
The detailed data of biochemical findings of each group are shown in Table 1 . Serum LDHlevels were higher than the normal upper limit in all the patients of Group 1 , and in less than one-halfofthe patients of Group 2. The levels of serum alkaline phosphatase, y-GT, and LAPwere also significantly different between groups (p<0.000 1 ). However, they were slightly above the normal range in most cases. The difference in serum bilirubin wasnot statistically significant. Choline esterase levels tended to be low comparedto the normal reference value in all three groups. Serumferritin levels tended to be high in all the groups and especially high in Group 1. As judged by the prothrombin time, thrombotest, and/or hepatoplastin tests, abnormal coagulation activity was observed in only 5 patients of Group1 and the abnormalities were mild even in the patients with markedly high aminotransferase levels. Although these abnormalities seemed to indicate hepatocellular injury, the patterns of LDHisozyme were varied, and only 5 patients of Group 1 showed slight elevation of isozyme of hepatic origin (isozyme 5 fraction: >10%). Serum creatine kinase levels were abnormally high in 1 0 patients of Group 1 and 4 patients showed markedly high CK levels (CK: >500 IU//).
The comparison of physical signs of the groups of patients clearly demonstrates that anorectic patients with high aminotransferase levels were of lower BMI (p<0.0001), lower body temperature (p<0.0001), and lower pulse rate (p<0.001) than anorectic patients with normal aminotransferase levels ( Table 2 ). There was no age difference between groups.
Internal Medicine Vol. 37, No. 1 (January 1998) The correlation between serum aminotransferase levels and BMI before the refeeding therapy is depicted in Fig. 1 . There was a significant inverse correlation of ALTand ASTlevels with BMI (r = -0.555, p<0.0001, and r = -0.581, p<0.0001, respectively). Among17 patients with aBMI of less than 12, the aminotransferase level was abnormally high in 13 patients (76%). Serum aminotransferase was normal when BMIwas greater than 15. Correlation coefficients between BMIand the biochemical and physical parameters are summarized in Table   3 . The most significant correlations were observed for AST, ALTand LDH. Serum levels of biliary tract enzymes, i.e. alkaline phosphatase, y-glutamyltransferase (y-GT), and LAP, showed a less significant correlation with BML When an appropriate caloric regimenwasstarted, calorie repletion consistently and quickly improved aminotransferase levels in these patients (Fig. 2) . The improvement of ami-10,000 -t 1 10,000 -i 1 notransferase levels was parallel to the increase of BMLFinally, all biochemical abnormalities disappeared by sufficient gain of body weight.
Twopatients showed similar aminotransferase level elevation, when the body weight declined again 2 or 3 years later. In these patients, the change in aminotransferase levels, i.e., decline, elevation and decline again, was apparently reciprocal with the change in their BML Aminotransferase elevation during refeeding therapy
After the initiation of refeeding therap>, mother type of abnormal elevation of aminotransferase developed in 28 patients of Group 3 whohad normal serum aminotransferase levels before refeeding therapy. Age distribution was 21.8 ± 6.3 years. This type of aminotransferase elevation was observed when BMIhad consistently increased from 13.3 to 14.6 by effective refeeding therapy with improvement of general conditions indicated by body temperature, pulse rate and blood pressure ( Figure 2 . The responses of serum ALTlevels and BMIto refeeding therapy in the anorectic patients who had markedly high ALTlevels (Group 1). Calorie repletion improved ALT levels (p<0.0001) consistently with the increase ofBMI (p<0.0001). ALT (IU/0 was expressed after logarithmic transformation, f: Number of patients. induced type of aminotransferase elevation (Median 14.6) was significantly higher (p<0.0001) than the BMI of the patients with pre-refeeding aminotransferase elevation (Median 1 1.6 and 13.3 in Groups 1 and 2, respectively). The period from the nadir of body weight to the peak of the aminotransferase elevation was 20.4 ± 9.5 (mean ± SD) days. The aminotransferase elevation of this type was rather mild (Table 5 ), compared to the abnormalities which developed before refeeding therapy shown in Table 1 . Serum LDHwas also slightly high, and LDHisozyme analysis revealed that isozyme 5 was high in most cases (>10% in 18 of20 studied). Although the increases in alkaline phosphatase, y-GT, and LAP were statistically significant, most were changes within the normal range. The decrease in bilirubin and creatinine seem to reflect the improvement of dehydration and further development ofrefeeding-edema which is sometimes seen shortly after the initiation of refeeding therapy. Aminotransferase levels were normalized by the continuation of refeeding therapy and further increase in body weight in all patients (data not shown).
Discussion
The present study in a large series of patients with anorexia nervosa clearly showed that the incidence and severity of high aminotransferase levels were markedly increased in the emaciated patients with lower body weight. Although there have been a numberof studies regarding the changes in aminotransferase in anorectic patients, they have shown no consistent patterns in the results. Somestudies revealed an abnormalvalue but most results lie within normal limits. Cravario et al (5) reported that only one of27 patients with an average BMIof 14.4 ± 2.0 (mean ± SD) showed elevated serum aminotransferase levels. Mira et al (6) reported that 2 of 22 anorectic patients, with body weight 73.2 ± 9.6% of standard body weight, showed elevated serum aminotransferase levels. In the report of Fichter and Pirke (7), there was no difference in ALTand ASTbetween groups of patients with less than 60%, 61-90%, and 91-1 10% of ideal body weight. In contrast, Herpertz-Dahlmann and Remschmidt (8) reported a statistically significant difference in AST and ALTbetween groups of patients with less than 80% and more than 80% of ideal body weight. Miner et al (9) emphasized the high incidence of serum AST elevation (45% of anorectic patients).
Umeki et al (10) also reported significantly high aminotransferase levels in anorectic patients which had improved at time of discharge. These discrepancies may be due to difference of the population of patients and the timing of measurements (2) . In the present study, the body weight loss tended to be more severe than in manyother studies (4-8, 1 1, 12). Whenaminotransferase levels were analyzed before the refeeding therapy, BMI was 13.2 ± 1.3 (mean ± SD), ranging from 9.9 to 16.4 kg/m2, which was 61.3 ± 6.2% (mean ± SD), ranging from 45.7 to 76.4% of standard body weight. This reflects the fact that the anorectic patients were referred and admitted to our department of internal medicine, especially when the patient's body weight loss became severe and required urgent medical treatment. The mechanismof the serum aminotransferase elevation is unclear. The elevation of aminotransferase has been attributed to nutritional liver damageand the association with abnormalities in other hepatocellular or biliary tract biochemical markers also suggests that aminotransferase elevation is due to hepatic disorder. However, aminotransferase exists in manyother organs, including heart, muscle, and kidneys. Thus, it is difficult to define their source exclusively as hepatic origin. LDH isozyme analysis indicates that the LDHisozyme pattern is varied. The isozyme 5 fraction, which is usually increased in hepatocellular injury, was elevated only in a small numberof patients even whenthe aminotransferase elevation was marked.
Some patients showed apparent CKelevation, suggesting the presence of muscle disorders. These findings support the concept that the source of elevated aminotransferase is multiple organs, not only the liver, in emaciated anorectic patients.
Internal Medicine Vol. 37, No. 1 (January 1998) These biochemical abnormalities seem simply due to the deranged metabolism induced by severe limitation of food intake. The disruption of compensation of metabolism to severe calorie deficiency occurs whenbody weight decreases to critically low levels and the shortage of calorie intake continues. This concept is supported by the finding that the severity and incidence are inversely well correlated with BMI. Additionally, the abnormalities subside relatively easily and rapidly after calorie repletion as shownin Fig. 2 In our study, we also analyzed the physical findings in the relation to aminotransferase elevation. In the patients with a marked elevation of aminotransferase, physical conditions were poorer, i.e. lower pulse rate and lower body temperature, compared to the patients with normal aminotransferase levels. This means the abnormally high levels of aminotransferase in anorectic patients is an important biochemical sign noting a very poor general condition which might be life-threatening. Whenmarked elevation of aminotransferase levels is observed in anorectic patients, immediate treatment, including bed rest and calorie repletion, should be instituted. Parenteral alimentation is an acceptable methodfor calorie repletion. The elevation of serumaminotransferase was the most significant abnormality among routine blood biochemical examinations in emaciated anorectic patients. Aminotransferase elevation seems to be the most simple and one of the best markers ofa critically deranged metabolic state, although many other biochemical, especially endocrinological abnormalities have been reported in patients with anorexia nervosa (1, 2) .
In the present study, another type of aminotransferase elevation was observed, the refeeding-induced type. This type of aminotransferase elevation is seen when the patient is gaining body weight after initiation of effective refeeding therapy. Compared to the emaciation-induced type, biochemical abnormalities in this type are generally mild and developed with higher body weight and better physical conditions. The developmentof aminotransferase elevation after refeeding is compatible with another report (1 1). The mechanismof this type of aminotransferase elevation seems to be purely due to liver origin. LDHisozyme analysis revealed that LDHtype 5 was elevated in most patients. It may be induced by an abrupt and rapid increase in calorie intake in an anorectic patient, even if the amount of calories supplied is far less than the normal requirement. It develops in the early phase of nutritional therapy and improves while the rate of weight increase continues. The pathophysiological mechanismof this type of aminotransferase elevation is probably the same as the well-known liver injury induced by parenteral nutrition in patients after surgery or with digestive tract diseases (27). These two types of aminotransferase elevation can be distinguished from each other by determining the pattern of abnormalities and the recent changes in body weight in manypatients. However, it is sometimes difficult to differentiate the mild emaciation-induced type from the refeeding-type especially when records of recent change in body weight and the amountof calorie intake are not available.
